This study indicates the potential of this recombinant protein for the prevention and treatment of viral diseases, providing data-based support and a theoretical basis for the future development of mammalian-cell-expressed IFN-α antiviral drugs. The gene discussed is IFNA1; the disease is viral infectious disease.